Casdin Capital, LLC 13D and 13G filings for MaxCyte, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | MaxCyte, Inc. MXCT |
Casdin Capital, LLC | 0 0.000% |
-9,220,000 (Position Closed) |
Filing |
| 2023-01-10 4:48 pm Sale |
2023-01-05 | 13G | MaxCyte, Inc. MXCT |
Casdin Capital, LLC | 9,220,000 9.020% |
-4,751,334 (-34.01%) |
Filing |
| 2021-08-03 5:16 pm Purchase |
2021-07-29 | 13G | MaxCyte, Inc. MXCT |
Casdin Capital, LLC | 13,971,334 14.200% |
13,971,334 (New Position) |
Filing |